Table 3. Stratified distribution of study variables and their association with availability of NCD medicines.
| Variable | N (%) | Essential medicines availability, n (%) | p* | ||
|---|---|---|---|---|---|
| None present | 1–3 present | 4 or more present | |||
| Lower primary facilities (n = 94) | |||||
| Region | 0.02 | ||||
| West | 14 (14.9) | 12 (85.7) | 0 (0.0) | 2 (14.3) | |
| North | 28 (29.8) | 15 (53.6) | 11 (39.3) | 2 (7.1) | |
| East | 32 (34.0) | 27 (84.4) | 3 (9.4) | 2 (6.3) | |
| South | 20 (21.3) | 11 (55.0) | 7 (35.0) | 2 (10.0) | |
| Managing authority | <0.01 | ||||
| Public | 61 (64.9) | 54 (88.5) | 6 (9.8) | 1 (1.6) | |
| Private non-profit | 14 (14.9) | 5 (35.7) | 6 (42.9) | 3 (21.4) | |
| Private for-profit | 19 (20.2) | 6 (31.6) | 9 (47.4) | 4 (21.1) | |
| HCT^ available | 53 (56.4) | 33 (62.3) | 12 (22.6) | 8 (15.1) | 0.03 |
| HIV care available | 33 (35.1) | 24 (72.7) | 6 (18.2) | 3 (9.1) | 0.78 |
| Primary and extended facilities (n = 102) | |||||
| Region | 0.04 | ||||
| West | 9 (8.8) | 0 (0.0) | 5 (55.6) | 4 (44.4) | |
| North | 35 (34.3) | 2 (5.7) | 18 (51.4) | 15 (42.9) | |
| East | 32 (31.4) | 5 (15.6) | 18 (56.3) | 9 (28.1) | |
| South | 26 (25.5) | 1 (3.9) | 14 (53.9) | 11 (42.3) | |
| Managing authority | <0.01 | ||||
| Public | 64 (62.8) | 6 (9.4) | 41 (64.1) | 17 (26.6) | |
| Private non-profit | 29 (28.4) | 1 (3.5) | 10 (34.5) | 18 (62.1) | |
| Private for-profit | 9 (8.8) | 1 (11.1) | 4 (44.4) | 4 (44.4) | |
| HCT^ available | 99 (97.1) | 8 (8.1) | 53 (53.5) | 38 (38.4) | 0.84 |
| HIV care available | 80 (78.4) | 6 (7.5) | 42 (52.5) | 32 (40.0) | |
Note: Percentages may not sum to 100% due to rounding. Frequencies and percentages reflect unweighted data.
* P-value for χ2 test.
^HCT = HIV Counseling and Testing